Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
STDs
Rise of drug-resistant gonorrhea creates opportunity for clinical labs: Report
According to the CDC, the “substantial decline” in gonorrhea culture testing and the reduced capability of laboratories to perform gonorrhea culture techniques for antibiotic susceptibility testing is a major challenge to monitoring drug resistance.
July 19, 2023
STI, HIV screening decreased during COVID-19 as cases increased
Testing for sexually transmitted infections and HIV declined during the pandemic despite increased cases, particularly in so-called safety net hospitals.
March 31, 2023
Becton Dickinson nabs FDA clearance for infectious vaginitis molecular test
The BD vaginal panel running on the high-throughput BD Cor molecular diagnostic system tests for multiple common types of vaginitis using only a swab and one test.
March 16, 2023
Birmingham AIDS Outreach, Binx Health launch accessible HIV/STI testing program in Alabama
The program will serve the Birmingham, AL, metro area by providing access to self-collection kits for HIV and sexually transmitted infections (STIs) through a network of trusted partners that work with higher-risk populations.
March 1, 2023
Binx Health, Afaxys Group Services expand access to sexual health and wellness testing
The collaboration will enable expanded access to Binx io, a point-of-care testing platform that has been CLIA-waived and received clearance from the FDA.
November 10, 2022
Binx Health, Alabama Department of Public Health collaborate on remote STI testing
Binx Health said that COVID-19, affordability, and privacy concerns have increased the number of people choosing to participate in remote sample collection services.
October 7, 2022
GoMeyra expands information management system to include panels for monkeypox, UTIs, STIs
The GoMeyra Laboratory Information Management Systems platform now processes tests for monkeypox, UTIs, and STIs. Respiratory and toxicology tests are in the planning stages.
September 29, 2022
COVID-19 highlights need for at-home STI testing
It has been widely reported that the COVID-19 pandemic has caused declines in rates for different screening exams, and the same holds for STI screenings, according to the authors, led by Ellen Kersh, PhD, of the U.S. Centers for Disease Control and Prevention (CDC).
October 25, 2021
New world order for STD tests | Red flags on CLIA-waived products | FDA's burst of preholiday actions
Dear LabPulse Member,
May 27, 2019
STD test market grows with incidence, new tech
Not that long ago, rates of gonorrhea infection were at historically low levels, and elimination of syphilis was a reasonable goal. The diagnostics industry was able to highlight how advances in STD detection and prevention brought increased rates of detection and treatment.
May 27, 2019
FDA clears 1st extragenital STD tests
The tests are designed to detect the presence of the bacteria Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) with extragenital specimens acquired via the throat and rectum. Previously, the tests were cleared only for use with urine, vaginal, and endocervical samples.
May 22, 2019
Quest sells STD tests directly to consumers
The company said the three packages are designed to meet the needs of individuals who want basic or comprehensive STD testing. It also said they are the first to be offered by a national laboratory directly for purchase by consumers.
April 17, 2019
Page 1 of 1
